学术报告：Hybrid microfluidic Lab-on-a-Chip and nanotechnologies for low-cost disease diagnosis

厦门大学谱学分析与仪器教育部重点实验室
biwn必赢
2016年6月15日

报告摘要：

Hybrid microfluidic Lab-on-a-Chip and nanotechnologies for low-cost disease diagnosis

XiuJun (James) Li, Ph.D.

^1:Department of Chemistry, ²: Border Biomedical Research Center (BBRC), ³: Biomedical Engineering (BME), ⁴:Material Science & Engineering (MASE), ⁵: Environmental Science & Engineering (ESE), University of Texas at El Paso, Texas, 79968

 
Infectious diseases and cancer are major “Killers” worldwide. The demands for rapid, accurate and low-cost early diagnosis of these diseases are challenging conventional diagnostic methods, especially in low-resource settings. Recently, fast growing microfluidic lab-on-a-chip and nanotechnologies have caused significant impact on modern disease diagnostics. Herein, I will highlight several paper/polymer hybrid microfluidic devices and nano-biosensing techniques that we recently developed for rapid disease diagnosis, especially for resource-poor settings. Difference chip substrates have different advantages as well as limitations. Paper/polymer hybrid microfluidic devices can draw more benefits from both substrates. Integrated graphene oxide nano-biosensors, on-chip DNA amplification and immunoassay, and nanoparticle-mediated photothermal immunosensing will also be discussed toward their applications in point-of-care infectious disease diagnosis and cancer biomarker detection.

附件：报告摘要及报告人简介